Ozempic Eligibility: Who Qualifies for a Prescription?

Last reviewed: July 2, 2026

Last updated: July 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide prescriptions require meeting specific clinical criteria beyond weight alone. PlexusDx assesses individual eligibility through a personalized medical review, ensuring compounded semaglutide therapy aligns with evidence-based guidelines and your unique health status.

BMI Requirements and Weight Loss Criteria

Body mass index thresholds form the foundation of semaglutide eligibility. Most candidates have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as type 2 diabetes, high blood pressure, or elevated cholesterol. Some patients with lower BMI may qualify if they demonstrate significant metabolic dysfunction or previous unsuccessful weight loss attempts.

PlexusDx reviews your complete weight history during the eligibility assessment. The evaluation includes prior weight loss efforts, current metabolic markers, and how your body has responded to diet and exercise changes. This personalized approach ensures that semaglutide is recommended only when lifestyle interventions alone have proven insufficient.

Medical Conditions That Support Semaglutide Qualification

Certain health conditions strengthen eligibility for semaglutide therapy. Type 2 diabetes, hypertension, sleep apnea, fatty liver disease, and cardiovascular risk factors all indicate that weight loss through semaglutide may provide metabolic benefits beyond appearance. Patients with a family history of heart disease or metabolic syndrome often qualify based on their elevated health risk profile.

PlexusDx providers evaluate how your existing health conditions interact with obesity. For example, a patient with poorly controlled diabetes and excess weight may benefit significantly from semaglutide's dual effects on blood sugar and appetite. Similarly, individuals with cardiovascular disease risk factors demonstrate clear clinical need for pharmacologic weight loss support alongside medication management.

Age, Medication History, and Health Screening

Age alone does not disqualify patients from semaglutide treatment. Adults of any age—from young adults with metabolic syndrome to older patients with multiple weight-related conditions—may be eligible. However, PlexusDx providers assess how current medications interact with semaglutide, ensuring no harmful drug interactions exist and that your kidney and liver function support safe use.

A complete health screening forms part of the eligibility process. This includes blood pressure measurement, fasting glucose or HbA1c testing, and liver function assessment. Patients with a history of thyroid cancer, medullary thyroid carcinoma, or certain pancreatitis conditions typically are not candidates. PlexusDx reviews all prior medical history to identify any contraindications before recommending compounded semaglutide injection.

How PlexusDx Determines Your Semaglutide Eligibility

PlexusDx eligibility assessment combines objective metrics with clinical judgment. Your BMI, weight loss history, current health conditions, medication list, and lab values all contribute to a comprehensive suitability review. No single factor determines eligibility—instead, the full clinical picture guides whether compounded semaglutide injection at $189/mo month-to-month, or from $149/mo on the 6-month plan is appropriate for your specific health needs.

After you qualify for semaglutide therapy, PlexusDx offers the option to add the Precision Peptide Genetic Test for $298. This genetic analysis examines key variants in appetite regulation and metabolism pathways, helping customize your treatment approach. Understanding your genetic predispositions enables more precise dose adjustments and medication selection as you progress through your weight loss journey.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the minimum BMI required to qualify for semaglutide with PlexusDx?

PlexusDx candidates typically have a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related health condition. However, eligibility depends on your complete health profile, not BMI alone. Your PlexusDx provider reviews your medical history, current medications, and metabolic status during a personalized assessment.

Do I need a diabetes diagnosis to qualify for compounded semaglutide?

No—semaglutide is prescribed for chronic weight management in patients without diabetes. While type 2 diabetes strengthens your candidacy, PlexusDx evaluates eligibility based on BMI, weight-related health conditions, and your metabolic profile. Many successful patients qualify through hypertension, sleep apnea, or elevated cardiovascular risk alone.

What lab tests does PlexusDx require before prescribing semaglutide injection?

PlexusDx typically requires blood pressure, fasting glucose or HbA1c, and basic liver and kidney function tests to ensure safe semaglutide use. Compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan), and your provider may recommend additional tests based on your health history. These screening tests prevent potential adverse effects and confirm semaglutide is appropriate for your condition.

Can I get semaglutide if I have tried and failed other weight loss medications?

Yes—previous unsuccessful attempts with other medications or lifestyle changes actually support semaglutide eligibility. PlexusDx recognizes that some patients require pharmacologic intervention, and your treatment history demonstrates genuine metabolic need. Your provider uses this information to strengthen the case for compounded semaglutide as part of your personalized weight loss plan.

How does the Precision Peptide Genetic Test help after I qualify for semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic Online Prescription
• Ozempic Prescription
• Ozempic Prescription Online
• Lifemd Ozempic

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.